Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fractyl Health, Inc. - Common Stock (NQ: GUTS ) 4.470 -0.030 (-0.67%) Streaming Delayed Price Updated: 11:58 AM EDT, Jul 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 57,877 Open 4.500 Bid (Size) 4.460 (3) Ask (Size) 4.510 (4) Prev. Close 4.500 Today's Range 4.420 - 4.560 52wk Range 3.980 - 14.50 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day June 25, 2024 Company will discuss recent corporate updates, including compelling preclinical data from Rejuva® pancreatic gene therapy platform, which was named top abstract at American Diabetes Association’s 84th... From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates June 24, 2024 From Fractyl Health, Inc. Via GlobeNewswire Performance YTD -65.21% -65.21% 1 Month -17.53% -17.53% 3 Month -32.78% -32.78% 6 Month -65.21% -65.21% 1 Year -65.21% -65.21% More News Read More Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s June 23, 2024 From Fractyl Health, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session June 06, 2024 Via Benzinga Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions May 29, 2024 From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024 May 20, 2024 From Fractyl Health, Inc. Via GlobeNewswire GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024 May 13, 2024 Via InvestorPlace Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates May 13, 2024 From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D) May 13, 2024 From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health to Present at BofA Securities 2024 Health Care Conference May 08, 2024 From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024 May 07, 2024 From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting April 30, 2024 From Fractyl Health, Inc. Via GlobeNewswire The 3 Most Volatile Stocks for Short-Term Traders: April 2024 April 17, 2024 Via InvestorPlace Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket April 03, 2024 Via Benzinga Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session April 03, 2024 Via Benzinga Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 02, 2024 Via Benzinga Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes April 02, 2024 From Fractyl Health, Inc. Via GlobeNewswire PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session April 02, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket April 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 01, 2024 Via Benzinga Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update April 01, 2024 From Fractyl Health, Inc. Via GlobeNewswire Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs April 01, 2024 From Fractyl Health, Inc. Via GlobeNewswire Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March March 19, 2024 Via Benzinga UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity March 12, 2024 From Fractyl Health, Inc. Via GlobeNewswire Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data March 12, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.